CCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 46 of 49 cases where CCEL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for CCEL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +10.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEL advanced for three days, in 150 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 79 of 97 cases where CCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The 10-day RSI Indicator for CCEL moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 24 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCEL as a result. In 109 of 119 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CCEL turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 44 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
CCEL moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.220) is normal, around the industry mean (204.532). P/E Ratio (-15.774) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (2.680) is also within normal values, averaging (2.498). Dividend Yield (0.123) settles around the average of (0.154) among similar stocks. P/S Ratio (1.141) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Stochastic Oscillator for OPCH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 73 similar instances where the indicator exited the overbought zone. In 50 of the 73 cases the stock moved lower. This puts the odds of a downward move at 68%.
The 10-day RSI Indicator for OPCH moved out of overbought territory on November 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 12 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPCH as a result. In 61 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for OPCH turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPCH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
OPCH broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 50-day moving average for OPCH moved above the 200-day moving average on October 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +0.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPCH advanced for three days, in 175 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 154 of 221 cases where OPCH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. OPCH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPCH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.763) is normal, around the industry mean (204.532). P/E Ratio (23.797) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.101) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.682) is also within normal values, averaging (2.688).
CCEL | OPCH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 72 | |
SMR RATING 1..100 | 12 | 54 | |
PRICE GROWTH RATING 1..100 | 40 | 38 | |
P/E GROWTH RATING 1..100 | 88 | 38 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CCEL's Valuation (7) in the null industry is significantly better than the same rating for OPCH (74). This means that CCEL’s stock grew significantly faster than OPCH’s over the last 12 months.
OPCH's Profit vs Risk Rating (72) in the null industry is in the same range as CCEL (100). This means that OPCH’s stock grew similarly to CCEL’s over the last 12 months.
CCEL's SMR Rating (12) in the null industry is somewhat better than the same rating for OPCH (54). This means that CCEL’s stock grew somewhat faster than OPCH’s over the last 12 months.
OPCH's Price Growth Rating (38) in the null industry is in the same range as CCEL (40). This means that OPCH’s stock grew similarly to CCEL’s over the last 12 months.
OPCH's P/E Growth Rating (38) in the null industry is somewhat better than the same rating for CCEL (88). This means that OPCH’s stock grew somewhat faster than CCEL’s over the last 12 months.
| CCEL | OPCH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 2 days ago 50% |
| Stochastic ODDS (%) | 1 day ago 85% | 2 days ago 68% |
| Momentum ODDS (%) | 1 day ago 90% | 2 days ago 63% |
| MACD ODDS (%) | 1 day ago 83% | 2 days ago 68% |
| TrendWeek ODDS (%) | 1 day ago 87% | 2 days ago 65% |
| TrendMonth ODDS (%) | 1 day ago 88% | 2 days ago 65% |
| Advances ODDS (%) | 7 days ago 70% | 10 days ago 60% |
| Declines ODDS (%) | 3 days ago 83% | 6 days ago 65% |
| BollingerBands ODDS (%) | 1 day ago 90% | 2 days ago 63% |
| Aroon ODDS (%) | 1 day ago 81% | 2 days ago 70% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CCEL’s FA Score shows that 2 FA rating(s) are green while OPCH’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CCEL’s TA Score shows that 6 TA indicator(s) are bullish while OPCH’s TA Score has 3 bullish TA indicator(s).
CCEL (@Hospital/Nursing Management) experienced а -4.93% price change this week, while OPCH (@Hospital/Nursing Management) price change was -0.06% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -10.44%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +3.25%.
CCEL is expected to report earnings on Feb 26, 2027.
OPCH is expected to report earnings on Feb 25, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that CCEL and NHC have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CCEL and NHC's prices will move in lockstep.
| Ticker / NAME | Correlation To CCEL | 1D Price Change % | ||
|---|---|---|---|---|
| CCEL | 100% | -9.94% | ||
| NHC - CCEL | 20% Poorly correlated | -2.03% | ||
| ADUS - CCEL | 20% Poorly correlated | -0.58% | ||
| BKD - CCEL | 20% Poorly correlated | -2.39% | ||
| OPCH - CCEL | 15% Poorly correlated | +0.25% | ||
| CMPS - CCEL | 13% Poorly correlated | +1.75% | ||
More | ||||
A.I.dvisor tells us that OPCH and FMS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPCH and FMS's prices will move in lockstep.
| Ticker / NAME | Correlation To OPCH | 1D Price Change % | ||
|---|---|---|---|---|
| OPCH | 100% | -0.25% | ||
| FMS - OPCH | 30% Poorly correlated | -0.78% | ||
| CYH - OPCH | 26% Poorly correlated | -5.16% | ||
| ADUS - OPCH | 26% Poorly correlated | -2.45% | ||
| JYNT - OPCH | 24% Poorly correlated | -0.15% | ||
| GRDN - OPCH | 24% Poorly correlated | +1.82% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CGV | 14.97 | -0.08 | -0.53% |
| Conductor Global Equity Value ETF (CGV) | |||
| JMEE | 72.65 | -0.99 | -1.34% |
| JPMorgan Small & Mid Cap Enhanced Equity ETF (JMEE) | |||
| DFNL | 50.01 | -1.06 | -2.08% |
| Davis Select Financial ETF (DFNL) | |||
| HEAL | 28.85 | -0.74 | -2.51% |
| Global X HealthTech ETF (HEAL) | |||
| BIDG | 3.91 | -0.33 | -7.89% |
| Leverage Shares 2X Long BIDU Daily ETF (BIDG) | |||